Implantable cardioverter-defibrillator leads serve as the critical interface between the defibrillation pulse generator and myocardial tissue, ensuring detection of arrhythmias and delivery of ...

Subcutaneous implantable cardioverter-defibrillator (S-ICD) therapies represent a significant advance in the prevention of sudden cardiac death. By positioning both the generator and the lead entirely ...

The Aurora EV-ICD and OmniaSecure defibrillation lead. [Images. courtesy of Medtronic] Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure ...

MINNEAPOLIS — Switching candidates for implantable cardioverter-defibrillator (ICD) implantation to a dual-function device that also modulates cardiac contractility was associated with successful ...

A 59-year-old Brugada patient underwent uncomplicated EV-ICD implantation. Remote monitoring hours later revealed multiple nonsustained ventricular tachycardia and ventricular oversensing-noise ...

Medtronic has won Food and Drug Administration approval for the Omniasecure defibrillation lead, the company said Friday. The lead connects to an implantable defibrillator and treats potentially life ...

A small-diameter, defibrillation lead that can be delivered through existing commercially available catheters for targeted placement is durable and safe, with no incidence of fractures at 1 year, the ...

BOSTON -- A novel small-diameter lead wire had a high level of success for delivery of implantable cardioverter-defibrillator (ICD) shocks and low complications, the LEADR pivotal trial showed. The ...

An electromagnetic therapy for depression shouldn't damage a person's pre-existing implantable cardioverter-defibrillator (ICD), multiple experiments indicated. There was a low risk of ICD damage or ...

It’s possible that consumer “smart” devices that come with bioimpedance technology to provide measurements of body composition can interfere with certain cardiac implantable electronic devices (CIEDs) ...